Sanofi/GSK: SP/GSK subunit B.1.351 vaccine

Vaccine Type: Protein Subunit

This vaccine may also be referred to as CoV2 preS dTM adjuvanted vaccine (B.1.351)

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 0 Trials

There are no trials for this phase.

Phase 3: 2 Trials

Approvals

This vaccine is not yet approved.

Registered Trials